Electrical Impedance-Based Characterization of Hepatic Tissue with Early-Stage Fibrosis.
3D cell culture
EIS
bile duct ligation
biopsy
circuit model
Journal
Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191
Informations de publication
Date de publication:
13 Feb 2022
13 Feb 2022
Historique:
received:
20
01
2022
revised:
09
02
2022
accepted:
11
02
2022
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
1
4
2022
Statut:
epublish
Résumé
Liver fibrosis is a key pathological precondition for hepatocellular carcinoma in which the severity is confidently correlated with liver cancer. Liver fibrosis, characterized by gradual cell loss and excessive extracellular matrix deposition, can be reverted if detected at the early stage. The gold standard for staging and diagnosis of liver fibrosis is undoubtedly biopsy. However, this technique needs careful sample preparation and expert analysis. In the present work, an ex vivo, minimally destructive, label-free characterization of liver biopsies is presented. Through a custom-made experimental setup, liver biopsies of bile-duct-ligated and sham-operated mice were measured at 8, 15, and 21 days after the procedure. Changes in impedance were observed with the progression of fibrosis, and through data fitting, tissue biopsies were approximated to an equivalent RC circuit model. The model was validated by means of 3D hepatic cell culture measurement, in which the capacitive part of impedance was proportionally associated with cell number and the resistive one was proportionally associated with the extracellular matrix. While the sham-operated samples presented a decrease in resistance with time, the bile-duct-ligated ones exhibited an increase in this parameter with the evolution of fibrosis. Moreover, since the largest difference in resistance between healthy and fibrotic tissue, of around 2 kΩ, was found at 8 days, this method presents great potential for the study of fibrotic tissue at early stages. Our data point out the great potential of exploiting the proposed needle setup in clinical applications.
Identifiants
pubmed: 35200376
pii: bios12020116
doi: 10.3390/bios12020116
pmc: PMC8869865
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Regione Piemonte
ID : Poli di Innovazione POR-FES 2014-2020 246 (EPATOCARE) and Piattaforma Tecnologica "Salute e Benessere" (EV-ER).
Références
Physiol Meas. 2007 Aug;28(8):813-28
pubmed: 17664674
J Hepatol. 2019 Jan;70(1):151-171
pubmed: 30266282
J Clin Med. 2019 Dec 24;9(1):
pubmed: 31878354
Biosens Bioelectron. 2016 Mar 15;77:56-61
pubmed: 26386332
Gynecol Oncol. 2009 Nov;115(2):267-71
pubmed: 19744703
Antioxid Redox Signal. 2022 Jan 4;:
pubmed: 34779230
BMC Syst Biol. 2015 Nov 20;9:83
pubmed: 26589287
NPJ Precis Oncol. 2019 Dec 17;3:33
pubmed: 31872065
Radiology. 2017 Sep;284(3):694-705
pubmed: 28128707
Transplant Proc. 2009 Jun;41(5):1677-81
pubmed: 19545706
Clin Liver Dis (Hoboken). 2019 Apr 30;13(4):114-116
pubmed: 31061705
Br J Surg. 2008 May;95(5):646-56
pubmed: 18196571
Talanta. 2021 Jan 15;222:121441
pubmed: 33167197
Arq Gastroenterol. 2018 Jan-Mar;55(1):2-6
pubmed: 29561971
Sci Rep. 2018 Jan 10;8(1):264
pubmed: 29321531
Panminerva Med. 2017 Dec;59(4):320-331
pubmed: 28880053
J Vis Exp. 2019 Dec 20;(154):
pubmed: 31904017
IEEE Trans Biomed Eng. 2012 Jun;59(6):1593-7
pubmed: 22410954
Sensors (Basel). 2021 May 20;21(10):
pubmed: 34065458
Biosens Bioelectron. 2020 Oct 1;165:112421
pubmed: 32729539
Physiol Meas. 2010 Jul;31(7):995-1009
pubmed: 20577035